Defective axonal transport in Alzheimer's disease

The normal function of amyloid precursor protein, involved in Alzheimer's disease, is to transport cellular materials along the axons.

Written byTudor Toma
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Alzheimer's dementia is caused by accumulation of amyloid-β protein in neurons, formed from proteolytisis of amyloid precursor protein (APP), but the normal role of APP in the brain remains unclear. In December 6, Nature Adeela Kamal and colleagues from University of California, San Diego show that APP is involved in transport within nerve cells and shunts cellular materials along the axons.

Kamal et al. investigated the role of APP in axonal transport by comparing the steady-state levels of kinesin-I (a microtubule motor protein) and putative kinesin-I cargoes in sciatic nerve axons, the dorsal root ganglion and corpus callosum from APP-null mutant and wild-type mice. They found that APP serves as a kinesin-I membrane receptor, mediating the axonal transport of β-secretase and presenilin-1 (Nature 2001, 414:643-648).

A previous study, from the same laboratory, demonstrated that proteolytic processing of APP generates a carboxy-terminal fragment of APP, which carries a cell death signal ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies